850 results on '"Scheetz, Marc"'
Search Results
2. Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams
3. Past, Present, and Future Biomarkers of Kidney Function and Injury: The Relationship With Antibiotics
4. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
5. International survey of antibiotic dosing and monitoring in adult intensive care units
6. 535: IMPACT OF VARIOUS EGFR EQUATIONS ON THE PHARMACOKINETICS OF MEROPENEM IN CRITICALLY ILL ADULTS
7. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients
8. Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults
9. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
10. Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
11. Antimicrobial Therapeutic Drug Monitoring in critically ill adult patients -an international perspective on access, utilisation, and barriers.
12. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
13. Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial Stewards
14. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections
15. Meta-analysis on safety of standard vs prolonged infusion of beta-lactams
16. Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
17. A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19
18. Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
19. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
20. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment
21. 535: IMPACT OF VARIOUS EGFR EQUATIONS ON THE PHARMACOKINETICS OF MEROPENEM IN CRITICALLY ILL ADULTS
22. 2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia
23. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
24. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study
25. Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
26. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
27. Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
28. Antimicrobial therapeutic drug monitoring in critically ill adult patients – An international perspective on access, utilisation, and barriers
29. Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials
30. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model.
31. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
32. Preclinical assessment of nirmatrelvir penetration into cerebrospinal fluid and central nervous system cells and tissues
33. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
34. Microsampling Assays for Pharmacokinetic Analysis and Therapeutic Drug Monitoring of Antimicrobial Drugs in Children: A Critical Review
35. Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model
36. International survey of antibiotic dosing and monitoring in adult intensive care units
37. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection
38. Vancomycin Prescribing and Therapeutic Drug Monitoring in Children With and Without Acute Kidney Injury After Cardiac Arrest
39. Engaging Pharmacy Students in Research Through Near-Peer Training
40. Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
41. Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
42. Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital
43. Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption
44. Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children.
45. Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy.
46. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
47. A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurement
48. Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
49. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model
50. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics : Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.